📰 Genentech News
Page 18 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
April 10, 2024
In a review, investigators focused on ranibizumab (Lucentis; Genentech), aflibercept (Eylea; Regeneron), and bevacizumab (Avastin; Genentech) as growth opportunities in the biosimilar space.
April 9, 2024
Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The
April 9, 2024
Despite the availability of anti-VEGF therapies, there is still a notable disease burden in older adults with vision-threatening retinal diseases.
April 9, 2024
/PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $10M in planned project...
April 9, 2024
NIIMBL Announces $10M for 8 New Biopharmaceutical Manufacturing Projects
April 8, 2024
An mRNA vaccine induced durable and functional T-cell responses that were associated with a reduced risk of disease recurrence in patients with pancreatic cancer,
April 8, 2024
A pancreatic cancer vaccine has continued to protect a small group of patients from their cancer coming back, three years after receiving the jab, a new study says.
April 8, 2024
CT141 mRNA-4157 Individualized Neoantigen Therapy +...
April 8, 2024
In this review, we discuss the most important recent developments in the biosimilars space, including new biosimilar approvals and launches, litigation under the Biologics Price...
April 8, 2024
A pancreatic cancer vaccine has continued to protect a small group of patients from their cancer coming back, three years after receiving the jab, a new study says.